1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. North America Cancer Biopsy Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Rising cancer incidence
3.2.1.2. Technological advancements
3.2.1.3. Growing emphasis on early detection
3.2.1.4. Awareness programs and screening campaigns
3.2.2. Restraints
3.2.2.1. Cost of biopsy procedures
3.2.2.2. Invasive nature of biopsy procedures
3.2.2.3. Challenges in biopsy result interpretation
3.2.3. Opportunities
3.2.3.1. Collaborations and partnerships
3.2.3.2. Growing emphasis on precision medicine
3.2.4. Challenges
3.2.4.1. Technological complexity
3.2.4.2. Data Privacy and ethical concerns
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. North America Cancer Biopsy Market: Marketing Strategies
5. North America Cancer Biopsy Market Overview
5.1. Market Size & Forecast, 2019-2030
5.1.1. By Value (USD Billion)
5.2. Market Share and Forecast
5.2.1. By Product
5.2.1.1. Instruments
5.2.1.2. Kits and Consumables
5.2.1.3. Services
5.2.2. By Type
5.2.2.1. Tissue Biopsy
5.2.2.2. Surgical Biopsy
5.2.2.3. Liquid Biopsy
5.2.2.4. Others
5.2.3. By Application
5.2.3.1. Breast Cancer
5.2.3.2. Colorectal Cancer
5.2.3.3. Cervical Cancer
5.2.3.4. Lung Cancers
5.2.3.5. Others (Including Liver Cancer, Blood Cancer, Prostate Cancer)
5.2.4. By End User
5.2.4.1. Hospitals
5.2.4.2. Diagnostic Laboratories
5.2.4.3. Others
5.2.5. By Country
5.2.5.1. United States
5.2.5.2. Canada
6. United States Cancer Biopsy Market
6.1. Market Size & Forecast, 2019-2030
6.1.1. By Value (USD Billion)
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Type
6.2.3. By Application
6.2.4. By End User
7. Canada Cancer Biopsy Market
7.1. Market Size & Forecast, 2019-2030
7.1.1. By Value (USD Billion)
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Type
7.2.3. By Application
7.2.4. By End User
8. Competitive Landscape
8.1. List of Key Players and Their Offerings
8.2. North America Cancer Biopsy Market Share Analysis, 2023
8.3. Competitive Benchmarking, By Operating Parameters
8.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
9. Impact of Geopolitical Tension on North America Cancer Biopsy Market
10. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
10.1. lllumina Inc
10.2. BD (Becton, Dickinson and Company)
10.3. Myriad Genetics Inc.
10.4. Thermo Fisher Scientific
10.5. BIOCEPT INC.
10.6. Hologic Inc
10.7. Danaher
10.8. Agilent Technologies Inc.
10.9. IZI Medical
10.10. Johnson & Johnson Services, Inc.
10.11. Medtronic
10.12. Boston Scientific Corporation
10.13. CONMED Corporation
10.14. INRAD, Inc.
10.15. Other Prominent Players
11. Key Strategic Recommendations
12. Research Methodology
12.1. Qualitative Research
12.1.1. Primary & Secondary Research
12.2. Quantitative Research
12.3. Market Breakdown & Data Triangulation
12.3.1. Secondary Research
12.3.2. Primary Research
12.4. Breakdown of Primary Research Respondents, By Country
12.5. Assumptions & Limitations
*Financial information of case of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable